Top 5 Health Care Stocks That Are Preparing To Pump In February
Top 5 Health Care Stocks That Are Preparing To Pump In February
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
醫療保健領域超賣次數最多的股票爲買入被低估的公司提供了機會。
The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro.
RSI 是一種動量指標，它比較股票在價格上漲的日子和價格下跌的日子的走勢。與股票的價格走勢相比，它可以讓交易者更好地了解股票在短期內的表現。根據Benzinga Pro的數據，當相對強弱指數低於30時，資產通常被視爲超賣。
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
以下是該行業主要超賣參與者的最新名單，RSI接近或低於30。
BIOLASE, Inc. (NASDAQ:BIOL)
BIOLASE, Inc.（納斯達克股票代碼：BIOL）
- On Jan. 29, Biolase reported full-year 2023 interim revenue of $48.9 million to $49.2 million, up 1% year-over-year compared to the consensus of $49.21 million. The company's stock fell around 43% over the past five days and has a 52-week low of $0.35 .
- RSI Value: 26.47
- BIOL Price Action: Shares of BIOLASE gained 11.6% to close at $0.4228 on Thursday.
- 1月29日，Biolase公佈的2023年全年中期收入爲4,890萬美元至4,920萬美元，同比增長1％，而市場普遍預期的4,921萬美元。該公司的股票在過去五天中下跌了約43％，並且 52 周低點爲 0.35 美元 。
- RSI 值：26.47
- BIOL價格走勢：週四，BIOLASE的股價上漲11.6％，收於0.4228美元。
CNS Pharmaceuticals, Inc. (NASDAQ:CNSP)
CNS 製藥公司（納斯達克股票代碼：CNSP）
- On Jan. 30, CNS Pharmaceuticals priced $4 million public offering of 13,333,334 common shares at $0.30 per share. The company's stock fell around 78% over the past month. It has a 52-week low of $0.2290.
- RSI Value: 22.30
- CNSP Price Action: Shares of CNS Pharmaceuticals rose 3.6% to close at $0.2528 on Thursday.
- 1月30日，CNS Pharmicals以每股0.30澳元的價格公開發行13,333,334股普通股，價值400萬美元。該公司的股票在過去一個月中下跌了約78％。它 創下 52 周低點 爲 0.2290 美元。
- RSI 值：22.30
- CNSP 價格走勢：週四，CNS Pharmicals的股價上漲3.6％，收於0.2528美元。
Revelation Biosciences, Inc. (NASDAQ:REVB)
啓示錄生物科學有限公司（納斯達克股票代碼：REVB）
- On Feb. 1, Revelation Biosciences announced the pricing of a $6.2 million offering. The company's stock fell around 80% over the past month and has a 52-week low of $2.40.
- RSI Value: 28.33
- REVB Price Action: Shares of Revelation Biosciences gained 7.8% to close at $2.78 on Thursday.
- 2月1日，Revelation Biosciences宣佈了620萬美元發行的定價。該公司的股票在過去一個月中下跌了約80％，爲期52周 低點爲2.40美元。
- RSI 值：28.33
- REVB價格走勢：Revelation Biosciences的股價上漲7.8％，週四收於2.78美元。
Gilead Sciences, Inc. (NASDAQ:GILD)
吉利德科學公司（納斯達克股票代碼：GILD）
- On Feb. 6, Gilead Sciences reported worse-than-expected fourth-quarter adjusted EPS results and issued FY24 revenue guidance below estimates. "The strength of the business provides a solid foundation as we enter a new catalyst-rich phase for the company. We are expecting several milestones in 2024, including updates on long-acting HIV prevention and treatment, Cell Therapy and Trodelvy," said Daniel O'Day, chairman and CEO of Gilead. The company's shares lost around 14% over the past month. The company's 52-week low is $72.87.
- RSI Value: 28.92
- GILD Price Action: Shares of Gilead Sciences fell 0.8% to close at $73.80 on Thursday.
- 2月6日，吉利德科學公佈的第四季度調整後每股收益低於預期，併發布的24財年收入指引低於預期。“隨着我們進入公司新的富含催化劑的階段，業務實力爲我們提供了堅實的基礎。我們預計2024年將有幾個里程碑，包括長效艾滋病毒預防和治療、細胞療法和Trodelvy的最新情況。” 吉利德董事長兼首席執行官丹尼爾·奧戴說。該公司的股價在過去一個月中下跌了約14％。該公司的52周低點爲72.87美元。
- RSI 值：28.92
- GILD價格走勢：週四，吉利德科學股價下跌0.8％，收於73.80美元。
Zai Lab Limited (NASDAQ:ZLAB)
Zai Lab Limited（納斯達克：ZLAB）
- Zai Lab said on Feb, 5, that it entered into uncommitted facility letter with the Bank of China (Hong Kong) Limited. The company's shares fell around 12% over the past five days. The company has a 52-week low of $19.07.
- RSI Value: 23.70
- ZLAB Price Action: Shares of Zai Lab fell 0.3% to close at $19.60 on Thursday.
- Zai Lab於2月5日表示，它與中國銀行（香港）有限公司簽訂了一份未承諾的貸款信函。該公司的股價在過去五天中下跌了約12％。該公司 創下 52 周低點 爲19.07美元。
- RSI 值：23.70
- ZLAB價格走勢：週四，Zai Lab的股價下跌0.3％，收於19.60美元。
Read More: Pinterest, PepsiCo And 3 Stocks To Watch Heading Into Friday
閱讀更多： 進入週五，Pinterest、百事可樂和三隻值得關注的股票
譯文內容由第三人軟體翻譯。